|
Status |
Public on Dec 01, 2023 |
Title |
ASO1 rep 2 |
Sample type |
RNA |
|
|
Source name |
Deceased female individual
|
Organism |
Homo sapiens |
Characteristics |
gender: female cell type: Primary hepatocyte cultures
|
Treatment protocol |
Hepatocytes in 12 well plates were treated for 72 hwith 60 nM final of ASO1, ASO2 or a Non-target ASO.
|
Growth protocol |
William's E, 10% serum, pen/strep and hepatocyte growth supplements (ThermoFisher)
|
Extracted molecule |
total RNA |
Extraction protocol |
High Pure RNA isolation using Trizol and cartridges
|
Label |
Biotin
|
Label protocol |
Standard Affymetrix protocol
|
|
|
Hybridization protocol |
Samples were hybridized to a Clariom_D array (Affymetrix) and scanned at the Centre for Applied Genomics (TCAG), Toronto
|
Scan protocol |
Array scanning was performed according to the manufacturer's instruction (Affymetrix)
|
Data processing |
Relative expression changes assessed by Expression Console
|
|
|
Submission date |
Nov 29, 2023 |
Last update date |
Dec 01, 2023 |
Contact name |
Ruth McPherson |
E-mail(s) |
rmcpherson@ottawaheart.ca
|
Organization name |
UOHI
|
Street address |
40 Ruskin
|
City |
Ottawa |
State/province |
Ontario |
ZIP/Postal code |
K1Y4W7 |
Country |
Canada |
|
|
Platform ID |
GPL23126 |
Series (1) |
GSE248931 |
TRIBAL/TRIBA1AL suppression in human hepatocytes |
|